Partnership Between ENT and Allergy Associates® and OralCDx® Continues to Help Save Lives

Oral cancer is rising among women, non-smokers and young people

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Suffern, NY (PRWEB) January 02, 2013

A mother of three in her early forties. An engineer in his mid-fifties. An artist in her late thirties. Oral cancer is rising among women, non-smokers and young people. ENT and Allergy Associates (ENTA) and OralCDx are working together to reduce the rate of the disease. In fact, in the year since the OralCDx BrushTest became available through ENTA’s 130 physician/36 clinical office practice, the partnership has helped save dozens of lives.

When Dr. Daniel Grinberg, an otolaryngologist at ENTA’s West Nyack, NY office, noticed a small white spot on the tongue of one of his patients, he brushed it with the BrushTest. The laboratory result showed abnormalities, and the non-smoker, who is in her forties, was subsequently diagnosed with oral squamous cell carcinoma, skin cancer of the mouth. The patient’s early diagnosis not only likely saved her life, but also potentially saved her from years of aggressive and debilitating treatments.

“We are seeing an increasing number of non-smokers with oral pre-cancer and cancer,” says Dr. Grinberg. “The OralCDx BrushTest makes it possible for me to test common looking spots that I see, even if the patient has no known risk factors.”

Dr. Daniel Scher, who practices in ENTA’s Wayne, NJ office, had a similar experience with a non-smoking patient who does not routinely drink. Dr. Scher noticed a red spot on the patient’s tongue and brushed it. As a follow up to the BrushTest, the patient was diagnosed with oral cancer early enough that it potentially saved his life.

“Finding pre-cancer in a patient who is in his early forties is, unfortunately, no longer as uncommon as it used to be,” explains Dr. Scher. “Studies have shown that an increasing number of younger people are diagnosed with oral cancer largely due to the human papillomavirus (HPV) and other unknown risk factors.”

To date, the OralCDx BrushTest has detected over 50,000 abnormalities, helping to prevent thousands of cancers and potentially saving thousands of lives.

About OralCDx BrushTest

OralCDx BrushTest (http://www.thebrushtest.com) is an easy, painless and definitive way for doctors to test the common small white and red oral spots that most people have in their mouth at one time or another. The BrushTest is used to determine if a common oral spot contains abnormal cells (known as dysplasia) that, if undetected, may develop into oral cancer. The OralCDx BrushTest is a non-invasive test for oral pre-cancer and cancer.

About ENT and Allergy Associates

ENT and Allergy Associates, LLP (http://www.entandallergy.com) is the largest and most comprehensive ear, nose, throat, allergy and audiology practice in the nation with 36 offices and over 130 physicians. Each location provides access to a full range of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, and Hearing Aid dispensing. The practice has a clinical alliance with the Mount Sinai Hospital for the treatment of diseases of the head and neck and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cancer. The Practice has also expanded its clinical capabilities to include advanced Immunodeficiency trials.


Contact

  • OralCDx

    (845) 369-7096
    Email